PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.13%
Negative revenue growth while RUN stands at 12.90%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-41.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
83.00%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
84.65%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
77.59%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
77.72%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
77.72%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.54%
Share reduction while RUN is at 1.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.54%
Reduced diluted shares while RUN is at 1.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
521.21%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
2000.43%
FCF growth above 1.5x RUN's 156.78%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7082.42%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
409.62%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
15.78%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
5951.95%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
311.99%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
141.29%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-498.12%
Negative 10Y net income/share CAGR while RUN is at 1473.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-595.14%
Negative 5Y net income/share CAGR while RUN is 1185.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-331.67%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
75.78%
5Y equity/share CAGR is in line with RUN's 72.95%. Walter Schloss would see parallel mid-term profitability and retention policies.
2.84%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.31%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.77%
Inventory shrinking or stable vs. RUN's 18.52%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.87%
Similar asset growth to RUN's 4.18%. Walter Schloss finds parallel expansions or investment rates.
-5.96%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.76%
Debt shrinking faster vs. RUN's 3.38%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-5.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.03%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.